---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-003966"
form_type: "8-K"
ticker: "PALI"
cik: "0001357459"
company_name: "PALISADE BIO, INC."
filed_at: "2023-02-08T23:59:59+00:00"
generated_at: "2026-06-19T21:35:04.110824+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Palisade Bio promotes Robert McRae to COO, appoints J.D. Finley to Board

## Summary
- Robert McRae appointed COO effective Feb 2, 2023; previously SVP of Operations and Strategic Development.
- J.D. Finley (interim CEO/CFO) appointed to Board as Class III director, expanding board from 7 to 8.
- Finley's base salary raised to $490K (from $440K) and target bonus increased to 45%, effective Oct 1, 2022.
- Conditional equity grants to officers: 81,500 options ($2.40, 10yr), 59,500 RSUs, 68,700 PSUs; require shareholder approval.
- PSUs vest 50% at $3.20 VWAP and 50% at $4.25 VWAP over 20 consecutive trading days.

## SEC filing metadata
- accession: 0001493152-23-003966
- form_type: 8-K
- ticker: PALI
- cik: 0001357459
- company_name: PALISADE BIO, INC.
- filed_at: 2023-02-08T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 3.02, 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1357459/000149315223003966/0001493152-23-003966-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1357459/000149315223003966/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-003966
- JSON: https://secwatch.observer/filing/0001493152-23-003966.json
- Plain text: https://secwatch.observer/filing/0001493152-23-003966.txt

## Key facts
- Executive change
  Robert McRae was appointed as Chief Operating Officer at PALISADE BIO, INC..
  - Action: appointed
  - Role: Chief Operating Officer
  source text: On February 2, 2023, the Company appointed Robert McRae as the Company’s Chief Operating Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1357459/000149315223003966/0001493152-23-003966-index.htm
- Executive change
  J.D. Finley was appointed as Director at PALISADE BIO, INC..
  - Action: appointed
  - Role: Director
  source text: On February 2, 2023, the Board appointed J.D. Finley to the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1357459/000149315223003966/0001493152-23-003966-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.